References
- Abrams, D. I., Vizoso, H. P., Shade, S. B., Jay, C., Kelly, M. E., and Benowitz, N. L. 2007. Vaporization as a smokeless cannabis delivery system: A pilot study. Clin. Pharmacol. Ther. 82:572–578.
- Bloor, R. N., Wang, T. S., Spanel, P., and Smith, D. 2008. Ammonia release from heated ‘street’ cannabis leaf and its potential toxic effects on cannabis users. Addiction 103:1671–1677.
- Chemic Laboratories. 2000. Proof of concept: Release of chemical constituents in Cannabis sativa at 170–180°C versus combustion. Unpublished report to California NORML and MAPS.
- Engels, F. K., de Jong, F. A., Mathijssen, R. H., Erkens, J. A., Herings, R. M., and Verweij, J. 2007. Medicinal cannabis in oncology. Eur. J. Cancer. 43:2638–2264.
- Gieringer, D. 2001. Cannabis vaporization: A promising strategy for smoke harm reduction. J. Cannabis Ther. 1:153–170.
- Gieringer, D. 1996. Marijuana research: Waterpipe study. MAPS (Multidisciplinary Association for Psychedelic Studies) Bull. 6:59–66.
- Gieringer, D., St.Laurent, J., and Goodrich, S. 2004. Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds. J. Cannabis Ther. 4:7–27.
- Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., and Verpoorte, R. 2006. Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol. J. Pharm. Sci. 95:1308–1317.
- McCarberg, B. H. 2007. Cannabinoids: their role in pain and palliation. J. Pain Palliat. Care Pharmacother. 21:19–28.
- Musty, E. R., and Rossi, R. 2001. Effects of smoked cannabis and oral 9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy: A review of state clinical trials. J. Cannabis Ther. 1:2001.
- Polen, M. R., Sidney, S., Tekawa, I. S., Sadler, M., and Friedman, G. D. 1993. Health care use by frequent marijuana smokers who do not smoke tobacco. West. J. Med. 158:596–601.
- Reinarman, C., Cohen, P. D. A., and Kaal, H. L. 2004. The limited relevance of drug policy: Cannabis in Amsterdam and in San Francisco. Am. J. Public Health 94:836–842.
- Russo, E. 2003. An interview with Markus Storz: June 19, 2002. J. Cannabis Ther. 3:67–78.
- Smith, P. F. 2007. Symptomatic treatment of multiple sclerosis using cannabinoids: Recent advances. Expert Rev. Neurother. 7:1157–1163.
- Tashkin, D. 1993. Is frequent marijuana smoking hazardous to health? West. J. Med. 158:635–637.
- Van der Kooy, F., Pomahacova, B., and Verpoorte, R. 2008a. Cannabis smoke condensate I: The effect of different preparation methods on tetrahydrocannabinol levels. Inhal. Toxicol. 20:801–804.
- Van der Kooy, F., Pomahacova, B., and Verpoorte, R. 2008b. Cannabis smoke condensate II: Influence of tobacco on tetrahydrocannabinol levels. Inhal. Toxicol. 21: 87–90.